Skip to main content
HNOI
OTC Energy & Transportation

HNO International Reveals a Second Toxic Convertible Note with Lambda Ventures, Doubling the Dilution Threat

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Energy
Sentiment info
Negative
Importance info
8
Price
$0.076
Mkt Cap
$7.779M
52W Low
$0.034
52W High
$0.677
52W Position info
124% above low
Off High info
89% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

HNOI has more than doubled off its 52-week low of $0.034 on light trading volume (0.1× avg).

Summary

HNO International's amended 8-K discloses a second, previously hidden convertible note deal with Lambda Ventures, doubling the toxic financing to $135,000 principal and 770,000 warrants. The deeply discounted conversion terms and massive share reserves intensify dilution risk for a company already fighting for survival.


Key Events · Financing and Capital Events · HNOI

  • Second Toxic Note Deal Disclosed

    The amendment reveals a previously omitted convertible note and warrant transaction with Lambda Ventures, LLC, identical to the Monroe Street Capital deal: $67,500 principal, $62,500 gross proceeds, $57,625 net, and 385,000 warrants at $0.25 exercise price.

  • Total Financing Doubles

    Combined with the Monroe Street deal, total toxic financing now stands at $135,000 principal, $125,000 gross proceeds, $115,250 net, and 770,000 warrants — doubling the dilution risk.

  • Deeply Discounted Conversion Terms

    Both notes convert at 60% of the lowest traded price over the prior 20 trading days, a 40% discount to market. At the current $0.076 stock price, the conversion price could be as low as $0.0456, implying massive potential share issuance.

  • Massive Share Reserve Requirements

    Each note requires a 20-million-share reserve, totaling 40 million shares — nearly 40% of the 101.8 million shares outstanding as of April 2026. The reserves can be increased unilaterally by the holders.


Analysis · HNOI · Energy & Transportation

This amendment uncovers a second convertible note and warrant deal with Lambda Ventures that had been previously omitted—mirroring the Monroe Street Capital transaction disclosed in May. Together, the two arrangements double the toxic financing to $135,000 in principal, $125,000 in gross proceeds, and 770,000 warrants at $0.25. The notes convert at a 40% discount to the lowest market price, and each requires a 20-million-share reserve—a massive overhang for a company with a $7.8 million market cap and a stock trading at $0.076. With the company already in severe financial distress and facing going-concern doubts, this hidden financing deepens the dilution risk and underscores the desperate capital-raising environment.

At the time of this filing, HNOI was trading at $0.08 on OTC in the Energy & Transportation sector, with a market capitalization of approximately $7.8M. The 52-week trading range was $0.03 to $0.68. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HNOI - Latest Insights

HNOI
Jul 15, 2026, 2:44 PM EDT
Filing Type: 8-K/A
Importance Score:
8
HNOI
Jul 07, 2026, 1:31 PM EDT
Source: Wiseek News
Importance Score:
8
HNOI
Jul 07, 2026, 1:22 PM EDT
Filing Type: 10-Q
Importance Score:
9
HNOI
May 08, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
8
HNOI
May 01, 2026, 5:33 PM EDT
Source: Wiseek News
Importance Score:
9
HNOI
May 01, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
9
HNOI
Apr 17, 2026, 12:21 PM EDT
Filing Type: 8-K
Importance Score:
9
HNOI
Apr 16, 2026, 11:23 AM EDT
Filing Type: 8-K
Importance Score:
7
HNOI
Mar 24, 2026, 5:34 PM EDT
Filing Type: 10-Q
Importance Score:
9
HNOI
Mar 17, 2026, 1:45 PM EDT
Filing Type: 8-K
Importance Score:
8